Benzinga's Top Upgrades, Downgrades For January 4, 2017

Top Upgrades

• Analysts at Evercore ISI Group upgraded Charles River Laboratories Intl. Inc CRL from Hold to Buy. Charles River shares rose 0.45 percent to close at $76.53 on Tuesday.
• Deutsche Bank upgraded HollyFrontier Corp HFC from Hold to Buy. HollyFrontier shares rose 2.47 percent to close at $33.57 on Tuesday.
• Baird upgraded Aecom ACM from Neutral to Outperform. AECOM shares rose 1.3 percent to $37.48 in pre-market trading.
• Analysts at FBR Capital upgraded Abercrombie & Fitch Co. ANF from Underperform to Market Perform. Abercrombie & Fitch shares rose 1.07 percent to $12.24 in pre-market trading.
• Piper Jaffray upgraded Hologic, Inc. HOLX from Neutral to Overweight. Hologic shares rose 0.10 percent to close at $40.16 on Tuesday.
• Analysts at Goldman Sachs upgraded ON Semiconductor Corp ON from Neutral to Buy. ON Semiconductor shares gained 2.92 percent to $13.05 in pre-market trading.
• Loop Capital upgraded Canadian Pacific Railway Limited (USA) CP from Hold to Buy. Canadian Pacific Railway shares fell 0.94 percent to close at $141.43 on Tuesday.
• Goldman Sachs upgraded State Street Corp STT from Neutral to Buy. State Street shares rose 1.97 percent to close at $79.25 on Tuesday.
• Analysts at Barclays upgraded Agilent Technologies Inc A from Equal-Weight to Overweight. Agilent shares rose 0.71 percent to $46.82 in pre-market trading.
• Analysts at Bank of America upgraded Altria Group Inc MO from Neutral to Buy.. Altria Group shares rose 1 percent to $68.30 in pre-market trading.

Top Downgrades

• Goldman Sachs downgraded BlackRock, Inc. BLK from Buy to Neutral. BlackRock shares fell 0.40 percent to $384.89 in pre-market trading.
• Stifel Nicolaus downgraded Anthem Inc ANTM from Buy to Hold. Anthem shares fell 0.37 percent to close at $143.24 on Tuesday.
• Analysts at Cowen & Co. downgraded JetBlue Airways Corporation JBLU from Outperform to Market Perform. JetBlue shares fell 0.31 percent to $22.32 in pre-market trading.
• Deutsche Bank downgraded Noble Energy, Inc. NBL from Buy to Hold. Noble Energy shares rose 0.97 percent to close at $38.43 on Tuesday.
• Credit Suisse downgraded Baker Hughes Incorporated BHI from Outperform to Neutral. Baker Hughes shares rose 0.09 percent to close at $65.03 on Tuesday.
• Analysts at Evercore ISI Group downgraded Intuitive Surgical, Inc. ISRG from Buy to Hold. Intuitive Surgical shares fell 0.59 percent to $638.00 in pre-market trading.
• Goldman Sachs downgraded Microsemi Corporation MSCC from Buy to Neutral. Microsemi shares rose 1.13 percent to close at $54.58 on Tuesday.
• Analysts at Imperial Capital downgraded Zebra Technologies Corp. ZBRA from Outperform to In-Line. Zebra Technologies shares rose 0.57 percent to close at $86.25 on Tuesday.
• DA Davidson downgraded J & J Snack Foods Corp JJSF from Buy to Neutral. J&J Snack shares fell 0.47 percent to close at $132.80 on Tuesday.
• Bank of America downgraded Philip Morris International Inc. PM from Buy to Neutral. Philip Morris shares fell 0.73 percent to $90.56 in pre-market trading.

Top Initiations

• Analysts at UBS initiated coverage on Athene Holding Ltd ATH with a Neutral rating. The price target for Athene Holding is set to $52. Athene Holding shares closed at $47.82 on Tuesday.
• Analysts at Leerink Swann initiated coverage on Achaogen Inc AKAO with an Outperform rating. The price target for Achaogen is set to $21. Achaogen shares closed at $13.00 on Tuesday.
• Analysts at Craig-Hallum initiated coverage on Fusion Telecommunications Int'l, Inc. FSNN with a Buy rating. The price target for Fusion Telecommunications is set to $3. Fusion Telecommunications shares closed at $1.45 on Tuesday.
• Analysts at Rodman & Renshaw initiated coverage of Ritter Pharmaceuticals Inc RTTR with a Buy rating. The price target for Ritter Pharmaceuticals is set to $7. Ritter Pharmaceuticals shares closed at $2.89 on Tuesday.
• Analysts at Roth Capital initiated coverage on Kite Pharma Inc KITE with a Buy rating. The price target for Kite Pharma is set to $68. Kite Pharma shares closed at $45.95 on Tuesday.
• Analysts at Canaccord Genuity initiated coverage on Teladoc Inc TDOC with a Buy rating. The price target for Teladoc is set to $24. Teladoc shares closed at $16.50 on Tuesday.
• Analysts at JPMorgan initiated coverage on Global Blood Therapeutics Inc GBT with an Overweight rating. The price target for Global Blood Therapeutics is set to $25. Global Blood Therapeutics shares closed at $14.30 on Tuesday.